DRD1 and attention deficit-hyperactivity disorder: In conclusion, our study provided a preliminary explanation the centrality of DA deficiency in the pathogenesis of ADHD and that the specific binding of DA and DRD1 elevates DA levels in the PFC and striatum by activating the cAMP/PKA signaling pathway, which may be an effective way to improve the core symptoms of ADHD.